BI 456906 vs Oxyntomodulin

Head-to-head comparison of BI 456906 (BI 456906, glucagon-like peptide-1/glucagon receptor dual agonist) and Oxyntomodulin (Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyBI 456906Oxyntomodulin
CategoryWeight ManagementWeight Management
Full NameBI 456906, glucagon-like peptide-1/glucagon receptor dual agonistEndogenous glucagon-like peptide 1 and glucagon co-agonist peptide
Molecular WeightN/A~4,200 Da
Half-LifeApproximately 1 week12-15 minutes
Amino AcidsN/A37
Typical DoseTrial-dependent; weekly SC dosingResearch doses vary; commonly 100-300 mcg in small human studies
RouteSubcutaneousSubcutaneous/IV
Purity≥98%≥98%
Studies Count1080
Research StatusClinicalClinical

BI 456906 Benefits

  • weight reduction
  • improved glucose control
  • lower liver-fat burden
  • enhanced satiety

Oxyntomodulin Benefits

  • reduces appetite
  • increases satiety
  • supports weight loss
  • improves postprandial metabolic signaling

BI 456906 Dosing

once-weekly subcutaneous injection|stepwise titration|ongoing maintenance phase

Oxyntomodulin Dosing

Research-only dosing|Subcutaneous or IV administration in trials|Pair with calorie restriction and monitoring

BI 456906 Side Effects

  • nausea
  • abdominal discomfort
  • diarrhea

Oxyntomodulin Side Effects

  • nausea
  • GI discomfort
  • decreased appetite beyond target

Research Overview

BI 456906

Preclinical and early clinical research support meaningful metabolic effects with a tolerable safety profile. It remains investigational and is not commercially available.

Oxyntomodulin

Human studies showed acute reductions in food intake and modest weight loss, helping establish the GLP-1 and glucagon co-agonism concept. It remains a foundational peptide for obesity and satiety research.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

BI 456906 stacks with:

metforminbupropion

Oxyntomodulin stacks with:

calorie-deficitresistance-training
glp1glucagondual-agonistweight-lossmetabolic-diseaseGLP-1glucagon-coagonistendogenous-peptideappetite-regulation